Molnár, D., Reznik, E., & Porrogi, P. (2026). From Genotype to Functional Risk: A Multi-Omic Approach to Predicting Thiopurine and Methotrexate Co-Therapy-Induced Liver Injury. Pharmaceuticals (14248247), 19(5), 733. https://doi.org/10.3390/ph19050733
Chicago Style (17th ed.) CitationMolnár, Dénes, Elizabeth Reznik, and Pálma Porrogi. "From Genotype to Functional Risk: A Multi-Omic Approach to Predicting Thiopurine and Methotrexate Co-Therapy-Induced Liver Injury." Pharmaceuticals (14248247) 19, no. 5 (2026): 733. https://doi.org/10.3390/ph19050733.
MLA (9th ed.) CitationMolnár, Dénes, et al. "From Genotype to Functional Risk: A Multi-Omic Approach to Predicting Thiopurine and Methotrexate Co-Therapy-Induced Liver Injury." Pharmaceuticals (14248247), vol. 19, no. 5, 2026, p. 733, https://doi.org/10.3390/ph19050733.